Nivestym 300 mcg (Filgrastim SOLUTION) 300 MCG

Nivestym 300 mcg is a solution used to stimulate the production of white blood cells. This intravenous medication supports the immune system, often used in cancer treatments and bone marrow transplants.

Strength

300 MCG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nivestym 300 mcg is primarily used to boost white blood cell counts. It is often administered to patients undergoing chemotherapy or bone marrow transplants to help their bodies recover. This medication supports the immune system by stimulating the production of neutrophils, a type of white blood cell crucial for fighting infections.

Side Effects

Common effects of Nivestym 300 mcg may include mild to moderate reactions at the injection site, such as redness or swelling. Some users might experience bone or muscle pain, headaches, or fatigue. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Precautions & Warnings

Nivestym 300 mcg should be handled with care and stored as directed. It is important to follow the prescribed administration guidelines to minimize risks. Patients with a history of allergic reactions to filgrastim or similar medications should inform their healthcare provider before use.

Avoid Interactions

Nivestym 300 mcg may interact with other medications, including those that suppress the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the effectiveness of this medication.

Frequently Asked Questions

Nivestym 300 mcg is used to stimulate the production of white blood cells, often in patients undergoing chemotherapy or bone marrow transplants.

Nivestym 300 mcg is administered intravenously, typically by a healthcare professional in a clinical setting.

Common side effects may include bone or muscle pain, headaches, fatigue, and mild reactions at the injection site.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions with Nivestym 300 mcg.

Patients with a history of allergic reactions to filgrastim or similar medications should inform their healthcare provider before using Nivestym 300 mcg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.